84890-62-0 Usage
Uses
Used in Pharmaceutical Industry:
2-(benzylthio)pyrimidine-4,6-diamine is used as a potential antineoplastic agent for its potential to target and treat cancer cells. Its specific structure allows it to interact with biological targets, which may lead to the inhibition of cancer cell growth and proliferation.
Used in Antiviral Applications:
In the field of antiviral drug development, 2-(benzylthio)pyrimidine-4,6-diamine is utilized as a potential antiviral agent. Its chemical properties may enable it to interfere with viral replication processes, thereby offering a therapeutic approach to combat viral infections.
Used in Medicinal Chemistry Research:
2-(benzylthio)pyrimidine-4,6-diamine serves as a valuable compound in medicinal chemistry for the design and development of new drugs. Its unique structure provides a foundation for creating derivatives with enhanced biological activities and selectivity, which can be crucial in the treatment of various diseases and disorders.
Further research and development of 2-(benzylthio)pyrimidine-4,6-diamine may pave the way for the discovery of novel therapeutic agents, expanding the arsenal of treatments available for patients suffering from cancer, viral infections, and other conditions.
Check Digit Verification of cas no
The CAS Registry Mumber 84890-62-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 8,4,8,9 and 0 respectively; the second part has 2 digits, 6 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 84890-62:
(7*8)+(6*4)+(5*8)+(4*9)+(3*0)+(2*6)+(1*2)=170
170 % 10 = 0
So 84890-62-0 is a valid CAS Registry Number.
84890-62-0Relevant academic research and scientific papers
Investigations into the origin of the molecular recognition of several adenosine deaminase inhibitors
Gillerman, Irina,Fischer, Bilha
experimental part, p. 107 - 121 (2011/03/19)
Inhibitors of adenosine deaminase (ADA, EC 3.5.4.4) are potential therapeutic agents for the treatment of various health disorders. Several highly potent inhibitors were previously identified, yet they exhibit unacceptable toxicities. We performed a SAR s
CHEMICAL COMPOUNDS - 795
-
Page/Page column 25, (2009/04/25)
The invention relates to chemical compounds, or pharmaceutically acceptable salts thereof of the formula (I): which have bacterial Murl inhibitory activity and are accordingly useful for their treatment and prophylaxis of bacterial infection, e.g., E.faec
Exploring 8-benzyl pteridine-6,7-diones as inhibitors of glutamate racemase (MurI) in Gram-positive bacteria
Breault, Gloria A.,Comita-Prevoir, Janelle,Eyermann, Charles J.,Geng, Bolin,Petrichko, Randy,Doig, Peter,Gorseth, Elise,Noonan, Brian
scheme or table, p. 6100 - 6103 (2009/07/18)
A successful scaffold-hopping approach gave a novel series of inhibitors of bacterial glutamate racemase (MurI). Early SAR studies of the 8-benzyl pteridine-6,7-diones led to compounds with micromolar enzyme potency and antibacterial activity.
